Agocoy, Julieta .

HRN: 02-51-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/02/2026
03/08/2026
IV
500MG
Q8
ABDOMINAL INFECTION
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: